TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
KLRA

Kailera Therapeutics, Inc.

Healthcare · Biotechnology

11.10$ -0.8% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Kailera Therapeutics, Inc. (KLRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 692 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KLRA
Line item 2024 2025
178 692
178 558
175 160
– 546
– 2.7
397 1,049
6.9 46
– 1.0
2.0 7.5
-219 -356
-220 -369
118 118

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?